Report overview
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
This report aims to provide a comprehensive presentation of the global market for Metastatic Colorectal Cancer Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Colorectal Cancer Surgery. This report contains market size and forecasts of Metastatic Colorectal Cancer Surgery in global, including the following market information:
Global Metastatic Colorectal Cancer Surgery Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Metastatic Colorectal Cancer Surgery market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
We surveyed the Metastatic Colorectal Cancer Surgery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metastatic Colorectal Cancer Surgery Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Metastatic Colorectal Cancer Surgery Market Segment Percentages, by Type, 2022 (%)
Tumor Resection
Portal Vein Embolization
Global Metastatic Colorectal Cancer Surgery Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Metastatic Colorectal Cancer Surgery Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Cancer Research Centers
Global Metastatic Colorectal Cancer Surgery Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Metastatic Colorectal Cancer Surgery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metastatic Colorectal Cancer Surgery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Metastatic Colorectal Cancer Surgery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Metastatic Colorectal Cancer Surgery, market overview.
Chapter 2: Global Metastatic Colorectal Cancer Surgery market size in revenue.
Chapter 3: Detailed analysis of Metastatic Colorectal Cancer Surgery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metastatic Colorectal Cancer Surgery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
